IF YOU HAVE PREVIOUSLY REGISTERED FOR THIS EVENT, PLEASE LOG IN BELOW OR CLICK THE LINK ON THE EMAIL YOU RECEIVED:
MSD

Diabetes Digital Dialogues 2018

Clinical Value of Using Oral Agents with Insulin for Type 2 Diabetics to Improve the Therapeutic Index of Insulin

Sethu Reddy

Sethu Reddy

Professor and Chair of Medicine, Central Michigan University College of Medicine, Mount Pleasant, Michigan, USA

Dr. Sethu Reddy is Senior Consultant and past-Chief of Adult Diabetes at JoslinDiabetes Center, Harvard, in Boston. He was previously Chairman of Endocrinology, Diabetes & Metabolism at Cleveland Clinic, currently ranked 2nd in the US by US News & World. He completed his undergraduate education at Memorial University of Newfoundlandand postgraduate training in Endocrinology & Metabolism at University of Toronto and in Molecular & Cellular Physiology at Joslin Diabetes Center, Harvard Medical School, Boston in 1988. Dr. Reddy has been actively involved in numerous clinically relevant projects with AACE since 1996 and is currently on the Board of Trustees for the American College of Endocrinology. In 2007, he received the distinction of Mastership in the American College of Endocrinology.

<table border="0" cellpadding="0" cellspacing="0" width="756" style="border-collapse: collapse;width:567pt"> <colgroup><col width="756" style="mso-width-source:userset;mso-width-alt:24192;width:567pt"> </colgroup><tbody><tr height="21" style="height:16.0pt">  <td height="21" class="xl65" width="756" style="height:16.0pt;width:567pt">Francisco  J. Pasquel</td> </tr></tbody></table>

Francisco J. Pasquel

Francisco J. Pasquel, MD, MPH, Assistan Professor of Medicine, Department of Medicine, Division of Endocrinology, Metabolism & Lipids, Emory University School of Medicine 

Francisco J. Pasquel, MD, MPH is Assistant Professor in the Department of Medicine at Emory University. He completed training in Internal Medicine and Endocrinology at Emory University School of Medicine and training in Epidemiology at the Rollins School of Public Health. He is an active member of the American Diabetes Association (ADA), American Association of Clinical Endocrinologists (AACE), and Endo Society. Dr. Pasquel has authored and co-authored over 45 peer-reviewed journal publications and book chapters. He conducts epidemiological and transitional research focused on understanding prognostic factors and mechanisms leading to complications in patients with diabetes, as well as clinical studies aiming at identifying the role of new treatment strategies for the outpatient and inpatient management of diabetes.   

WEBCAST WILL BE TRANSMITTED LIVE ON: 
05 June 2018, 07:00 (EDT), New Jersey (US)

WEBCAST WILL BE AVAILABLE ON DEMAND ON:
05 June 2018, 12:00 (EDT), for 24 hours 

EDT (Eastern Daylight Time) or UTC -4 (Universal Time Coordinated)
Note: Times shown are equivalent across the globe – adjust your calendars to your preferred time zone. Customers can view the webcast in its entirety at any time during these time frames.


Agenda

Agenda


07:00-07:05 (5 minutes)

Welcome and Opening Remarks

Sethu Reddy


07:05-07:30 (25 minutes)

Clinical Value of Using Oral Agents with Insulin for Type 2 Diabetics to Improve the Therapeutic Index of Insulin

Francisco J. Pasquel


07:30-07:55 (25 minutes)

Q&A

Sethu Reddy, Francisco J. Pasquel


07:55-08:00 (5 minutes)

Final Comments and Summary

Sethu Reddy